Liu established machine learning models based on CT images from diverse centers, proving their utility in assessing EGFR status in non-small cell lung cancer patients, with the RF model surpassing LR, DT, and SVM models (Liu et al., 2022; Ma et al., 2023). This evidence concerns the gene EGFR and non-small cell lung carcinoma.